Loading...
patent
Il-10 expressing cells for enhanced cancer immunotherapies
2023
The present invention relates generally to the field of anti-cancer therapy, in particular to the use of adoptive T cell transfer therapy for treating cancer, in particular sold tumors. More specifically, the present invention relates to immune cells comprising one or more recombinant constructs, wherein at least one recombinant construct encodes an interleukin-10, a fragment or a variant thereof.
Use this identifier to reference this record
Type
patent
EPO Family ID
77499640
Inventors
Note
Alternative title(s) : (fr) Cellules exprimant l'il-10 pour immunothérapies anticancéreuses améliorées
TTO classification
TTO:6.2224
EPFL units
Patent number | Country code | Kind code | Date issued |
CN118043450 | CN | A | 2024-05-14 |
KR20240049813 | KR | A | 2024-04-17 |
AU2022334870 | AU | A1 | 2024-03-28 |
WO2023025788 | WO | A1 | 2023-03-02 |
CA3228536 | CA | A1 | 2023-03-02 |
Available on Infoscience
April 3, 2023